Tirzepatide at the highest doses (15 mg) may be associated with slightly more GI side effects, which makes sense given its additional GIP receptor activity
It is found in high concentrations in the liver, where it binds to heavy metals such as mercury and lead, as well as metabolic wastes, and transforms them into a form that can be easily flushed out of the body
Skipping dose steps or self-injecting more than prescribed accelerates the risk of overdose-related complications
The trade-off is supposed to be scale in exchange for federal oversight
This release subsequently triggers the STING-IRF3 (interferon regulatory factor 3)/NF-B axis, and simultaneously promotes the activation of cGAS-STING-TBK1(TANK-binding kinase 1)-IRF3 and macrophage migration, which promotes inflammation and macrophage apoptosis (Fan et al., 2024)
Patients typically begin with a lower dose, gradually increasing it to help the body adjust and minimize side effects